Ticker: CMPS

Company Overview: Compass Pathways plc (NASDAQ: CMPS), is a biotechnology company focused on developing its investigational COMP360 psilocybin treatment for mental health disorders, particularly treatment-resistant depression (TRD). Recent Financial Performance: Net Loss: In Q2 2025, the company...